Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetically”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01343043
What this trial is testing

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

Who this might be right for
Neoplasms
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT02367014
What this trial is testing

Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy

Who this might be right for
Mitochondrial Myopathy
Stealth BioTherapeutics Inc. 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03779334
What this trial is testing

Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 26
Early research (Phase 1)Active Not RecruitingNCT01815749
What this trial is testing

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+21 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00842634
What this trial is testing

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

Who this might be right for
HIVHIV Infections
University of Pennsylvania 12
Testing effectiveness (Phase 2)Ended earlyNCT01875237
What this trial is testing

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Who this might be right for
LeukemiaMyelomaMyeloproliferative Diseases
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT03875495
What this trial is testing

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Who this might be right for
Multiple Myeloma
Genenta Science 9
Testing effectiveness (Phase 2)Study completedNCT03695939
What this trial is testing

Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds

Who this might be right for
Deep Full-thickness Burn Injury (Disorder)
XenoTherapeutics, Inc. 25
Not applicableLooking for participantsNCT05773729
What this trial is testing

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia

Who this might be right for
β-thalassemia
Shanghai BDgene Co., Ltd. 10
Not applicableEnrolling By InvitationNCT05627674
What this trial is testing

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

Who this might be right for
SmokingSmoking CessationTobacco Use Cessation
Washington University School of Medicine 915
Early research (Phase 1)Ended earlyNCT00272870
What this trial is testing

Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy

Who this might be right for
Glioblastoma Multiforme (WHO Grade IV)Anaplastic Astrocytoma (WHO Grade III)
Children's Hospital Medical Center, Cincinnati 1
Testing effectiveness (Phase 2)Ended earlyNCT02849886
What this trial is testing

T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

Who this might be right for
Graft Versus Host DiseaseHematological Malignancies
Centre Hospitalier Universitaire de Besancon 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05234190
What this trial is testing

Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

Who this might be right for
Rejection; Transplant, LiverLiver FailureLiver Diseases
Quell Therapeutics Limited 33
Early research (Phase 1)Study completedNCT00006480
What this trial is testing

Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Fred Hutchinson Cancer Center
Early research (Phase 1)WithdrawnNCT03506802
What this trial is testing

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

Who this might be right for
HLA-A*0201 Positive Cells PresentNY-ESO-1 Positive Tumor Cells PresentRecurrent Plasma Cell Myeloma+1 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00742664
What this trial is testing

Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project

Who this might be right for
Prader Willi SyndromeObsessive-compulsive Disorder
University of South Florida 24
Early research (Phase 1)UnknownNCT02331693
What this trial is testing

CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR

Who this might be right for
Advanced Glioma
RenJi Hospital 10
Not applicableStudy completedNCT04529720
What this trial is testing

5-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Who this might be right for
Pertussis
Mahidol University 159
Testing effectiveness (Phase 2)Study completedNCT01740557
What this trial is testing

Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
M.D. Anderson Cancer Center 10
Early research (Phase 1)Ended earlyNCT03168438
What this trial is testing

Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma

Who this might be right for
Neoplasms
GlaxoSmithKline 6
Next Page
30